» Authors » Paul Gordon

Paul Gordon

Explore the profile of Paul Gordon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 100
Citations 1671
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Merdler I, Rogers T, Case B, Zhang C, Gordon P, Ehsan A, et al.
Catheter Cardiovasc Interv . 2024 Aug; 104(3):583-590. PMID: 39109463
Background: In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low-risk patients with symptomatic severe tricuspid aortic stenosis. However, bicuspid aortic valve (BAV)...
2.
Ahmad K, Mentias A, Imran H, Elbadawi A, Hyder O, Gordon P, et al.
Rev Cardiovasc Med . 2024 Jul; 24(2):49. PMID: 39077422
Since its food and drug administration (FDA) approval in 2011, transcatheter aortic valve replacement (TAVR) has revolutionized the highly prevalent disease of aortic stenosis. In this review, we present a...
3.
Imran H, Ahmad K, Baig M, Elgendy I, Iqbal N, Ehsan A, et al.
Rev Cardiovasc Med . 2024 Jul; 24(1):15. PMID: 39076866
Background: Transcatheter edge-to-edge repair of mitral valve (M-TEER) is reasonable consideration in symptomatic patients with severe degenerative mitral regurgitation (MR) who are at high or prohibitive risk of surgical repair...
4.
Hagen K, Gordon P, Frederick A, Palmer A, Edalat P, Ricci Zonta Y, et al.
Neurobiol Aging . 2024 Feb; 133:1-15. PMID: 38381471
Evidence indicates that dysfunction of older Schwann cells and macrophages contributes to poor regeneration of more mature peripheral nervous system (PNS) neurons after damage. Since the underlying molecular factors are...
5.
Elkaryoni A, Saad M, Darki A, Abdelkarim I, Has P, Hyder O, et al.
Am J Cardiol . 2023 Oct; 209:184-189. PMID: 37858596
Patients with persistent severe mitral regurgitation after transcatheter aortic valve replacement (TAVR) may benefit from mitral transcatheter edge-to-edge repair (M-TEER). Using the Nationwide Readmission Database, we identified patients who had...
6.
Bhogal S, Waksman R, Shea C, Zhang C, Gordon P, Ehsan A, et al.
Int J Cardiol . 2023 Oct; 395:131431. PMID: 37832606
Background: Recent randomized studies have broadened the indication of transcatheter aortic valve replacement (TAVR) to also include low-surgical-risk patients. However, the data on self-expanding (SE) and balloon-expandable (BE) valves in...
7.
Schaible P, Gordon P, Kalimuthu R, Omi E, Schaible K
J Neurosurg Case Lessons . 2023 Sep; 6(10). PMID: 37728242
Background: An esophageal fistula secondary to a traumatic upper thoracic (T3-4) fracture with resultant thoracic discitis/osteomyelitis and an epidural abscess with neurological compromise is a rare clinical entity. Early diagnosis...
8.
Crossin R, Cleland L, Wilkins C, Rychert M, Adamson S, Potiki T, et al.
J Psychopharmacol . 2023 Jun; 37(9):891-903. PMID: 37353972
Aims: The harms arising from psychoactive drug use are complex, and harm reduction strategies should be informed by a detailed understanding of the extent and nature of that harm. Drug...
9.
Waksman R, Bhogal S, Gordon P, Ehsan A, Wilson S, Levitt R, et al.
Circ Cardiovasc Interv . 2023 May; 16(5):e012655. PMID: 37192308
Background: The LRT trial (Low-Risk Transcatheter Aortic Valve Replacement [TAVR]) demonstrated the safety and feasibility of TAVR in low-risk patients, with excellent 1- and 2-year outcomes. The objective of the...
10.
Bhogal S, Waksman R, Gordon P, Ehsan A, Wilson S, Levitt R, et al.
Int J Cardiol . 2022 Oct; 371:305-311. PMID: 36272571
Background: Subclinical leaflet thrombosis (SLT) is characterized on computed tomography (CT) imaging as hypoattenuated leaflet thickening (HALT), reduced leaflet motion (RELM), and hypoattenuation affecting motion (HAM). How antithrombotic regimen type...